DE69115135D1 - 1-Alkyl-3-(Acylamino)-Epsilon-Caprolactame zur Verbesserung der Lernfähigkeit und des Gedächtnisses und diese enthaltende pharmazeutische Zubereitungen. - Google Patents

1-Alkyl-3-(Acylamino)-Epsilon-Caprolactame zur Verbesserung der Lernfähigkeit und des Gedächtnisses und diese enthaltende pharmazeutische Zubereitungen.

Info

Publication number
DE69115135D1
DE69115135D1 DE69115135T DE69115135T DE69115135D1 DE 69115135 D1 DE69115135 D1 DE 69115135D1 DE 69115135 T DE69115135 T DE 69115135T DE 69115135 T DE69115135 T DE 69115135T DE 69115135 D1 DE69115135 D1 DE 69115135D1
Authority
DE
Germany
Prior art keywords
acylamino
epsilon
alkyl
memory
caprolactams
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69115135T
Other languages
English (en)
Other versions
DE69115135T2 (de
Inventor
Fabio Giannessi
Orlando Ghirardi
Domenico Misiti
Maria Ornella Tinti
Roberto Cozzolino
Carlo Scolastico
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of DE69115135D1 publication Critical patent/DE69115135D1/de
Publication of DE69115135T2 publication Critical patent/DE69115135T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE69115135T 1990-06-21 1991-06-20 1-Alkyl-3-(Acylamino)-Epsilon-Caprolactame zur Verbesserung der Lernfähigkeit und des Gedächtnisses und diese enthaltende pharmazeutische Zubereitungen. Expired - Fee Related DE69115135T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT04808790A IT1247698B (it) 1990-06-21 1990-06-21 1-alchil-3-(acilammino)-e-caprolattami quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti

Publications (2)

Publication Number Publication Date
DE69115135D1 true DE69115135D1 (de) 1996-01-18
DE69115135T2 DE69115135T2 (de) 1996-05-09

Family

ID=11264450

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69115135T Expired - Fee Related DE69115135T2 (de) 1990-06-21 1991-06-20 1-Alkyl-3-(Acylamino)-Epsilon-Caprolactame zur Verbesserung der Lernfähigkeit und des Gedächtnisses und diese enthaltende pharmazeutische Zubereitungen.

Country Status (9)

Country Link
US (1) US5155102A (de)
EP (1) EP0462949B1 (de)
JP (1) JPH04230266A (de)
AT (1) ATE131159T1 (de)
DE (1) DE69115135T2 (de)
DK (1) DK0462949T3 (de)
ES (1) ES2081463T3 (de)
GR (1) GR3019076T3 (de)
IT (1) IT1247698B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU756174B2 (en) * 1999-02-09 2003-01-09 Bristol-Myers Squibb Company Lactam inhibitors of FXa and method
WO2000047207A1 (en) 1999-02-09 2000-08-17 Bristol-Myers Squibb Company LACTAM INHIBITORS OF FXa AND METHOD
US6344450B1 (en) 1999-02-09 2002-02-05 Bristol-Myers Squibb Company Lactam compounds and their use as inhibitors of serine proteases and method
US6511973B2 (en) 2000-08-02 2003-01-28 Bristol-Myers Squibb Co. Lactam inhibitors of FXa and method
CN103393691A (zh) * 2003-12-01 2013-11-20 剑桥企业有限公司 抗炎药
EP1732885A1 (de) * 2004-02-23 2006-12-20 Trustees Of Tufts College Lactame als konformationsgehinderte peptidomimetische inhibitoren
GB2418425B (en) * 2004-08-11 2008-09-03 Univ Cambridge Tech Anti-inflammatory agents
GB201009603D0 (en) 2010-06-08 2010-07-21 Cambridge Entpr Ltd Anti-inflammatory agent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1231921B (it) * 1989-06-12 1992-01-15 Sigma Tau Ind Farmaceuti 1-acil-2-pirrolidoni quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
IT1231477B (it) * 1989-07-12 1991-12-07 Sigma Tau Ind Farmaceuti (pirrolidin-2-one-1-il) acetammidi quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti

Also Published As

Publication number Publication date
DE69115135T2 (de) 1996-05-09
IT9048087A0 (it) 1990-06-21
GR3019076T3 (en) 1996-05-31
IT1247698B (it) 1994-12-30
EP0462949B1 (de) 1995-12-06
JPH04230266A (ja) 1992-08-19
US5155102A (en) 1992-10-13
DK0462949T3 (da) 1996-02-05
EP0462949A1 (de) 1991-12-27
IT9048087A1 (it) 1991-12-21
ATE131159T1 (de) 1995-12-15
ES2081463T3 (es) 1996-03-16

Similar Documents

Publication Publication Date Title
IL108087A (en) 2-substituted-3-azaindolyl- acrylonitrile and 3-(azaindolyl-methylene) oxindole derivatives, process for their preparation and pharmaceutical compositions containing them
IL99889A0 (en) Azasteroid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
PH23739A (en) Piperidine derivative and pharmaceutical composition
IL109526A0 (en) Benzofuranyl- and thiophenyl-alkanecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
IL102759A0 (en) Hydantoin derivatives,their preparation and pharmaceutical compositions containing them
FI882081A (fi) 2-substituerade e-fusionerade (1,2,4) triazolo(1,5-c) pyrimidiner, farmaceutiska kompositioner och deras anvaendning.
TW427982B (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them
IL66341A0 (en) Pyrrolidine derivatives,their manufacture and pharmaceutical compositions containing them
DE69115135D1 (de) 1-Alkyl-3-(Acylamino)-Epsilon-Caprolactame zur Verbesserung der Lernfähigkeit und des Gedächtnisses und diese enthaltende pharmazeutische Zubereitungen.
GB9215844D0 (en) Novel compounds
DE69205073D1 (de) 3-Acylamino-2-pyrrolidinone zur Verbesserung der Lernfähigkeit und des Gedächtnisses und diese enthaltende pharmazeutische Zubereitungen.
IL83841A (en) 5-membered heterocyclic ring compounds substituted by phenyl and pyrrolidin-2-yl,their preparation and pharmaceutical compositions containing them
ATE116855T1 (de) 3-amino-epsilon-caprolactam enthaltende pharmazeutische zusammensetzungen zur verbesserung des lernvermögens und des gedächtnisses.
DE69011781T2 (de) 1-acyl-2-pyrrolidinone zur Verbesserung der Lernfähigkeit und des Gedächtnisses und diese enthaltende pharmazeutische Zubereitungen.
ATE100463T1 (de) Renin-hemmende aminooligohydroxy-derivate.
GR82272B (de)
ES2023760A6 (es) Procedimiento para la preparacion de derivados benzotiazinicos.
ZA83771B (en) Substituted thienobenzodiazepinones and acid addition salts thereof,processes for the preparation thereof and pharmaceutical compositions containing these compounds
SE8804696L (sv) Dioxazocin- derivat, deras framstaellning och beredningar innehaallande desamma
DE59204302D1 (de) 14Alpha,16alpha-Ethano- und 14alpha,16alpha-Ethenoestratriene.
IT1249062B (it) Derivati dell'eserolina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizuini farmaceutiche che li contengono.
ES2056721A1 (es) Mejoras en el objeto de la patente de invencion n{ 9101355 que se refiere a procedimiento de obtencion de nuevos derivados de platino con aminopirrolidinas.
IL70062A0 (en) Gamma-butyrolactone derivatives,their preparation and pharmaceutical compositions containing them
IT1247921B (it) Composti ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1248068B (it) Derivati dell'eseridina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee